Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Originally founded as the American arm of Germany’s Merck Group in 1891, the company has grown into a leader in the industry, ranking among the top five pharmaceutical firms by revenue.

Davis, Chairman and CEO, Merck. Founded in 1891, Merck (NYSE:MRK) is a global pharmaceutical company that develops prescription medicines, vaccines, biologic therapies, and animal health products.

Is now the time to initiate a position? Find out in our full research report, it’s free. Founded in 1891, Merck (NYSE:MRK) is a global pharmaceutical company that develops prescription medicines, ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

The shares were sold at a weighted average price of $61.1891, resulting in a total transaction ... and potential European Union launch in 2025. Merck (NSE:PROR) KGaA is in advanced discussions ...

The stock is down 3.1% since reporting and currently trades at $61.46. Founded in 1891, Merck (NYSE:MRK) is a global pharmaceutical company that develops prescription medicines, vaccines ...

In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats. Trump ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...